Pelthos Therapeutics is a biopharmaceutical company committed to commercializing innovative therapeutic products for high unmet patient needs. The company’s lead product is ZELSUVMI™ (berdazimer) topical gel, 10.3%, for the treatment of Molluscum contagiosum.
Company Details
- Employees
- 69
- Founded
- -
- Address
- 4020 Stirrup Creek Dr,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.pelthos.com
- Keywords
- for at-home delivery through mail-order pharmacies. Read the announcement: https://bit.ly/3ImjRbK.
- HQ
- Durham, NC
Pelthos Therapeutics Questions
Pelthos Therapeutics's website is http://www.pelthos.com
Pelthos Therapeutics's LinkedIn profile is https://www.linkedin.com/company/pelthos
Pelthos Therapeutics has
69 employees.
View email and phone details for 69
employees at Pelthos Therapeutics.
Pelthos Therapeutics's industry is
Pharmaceutical Manufacturing
Pelthos Therapeutics's top competitors are
Incyte,
Madrigal Pharmaceuticals,
Crinetics Pharmaceuticals,
Acadia Pharmaceuticals Inc.,
Verona Pharma,
Collegium Pharmaceutical, Inc.,
Corcept Therapeutics,
Viking Therapeutics, Inc.,
Channel Therapeutics,
Ligand Pharmaceuticals.
Pelthos Therapeutics's categories are Pharmaceutical Manufacturing
Pelthos Therapeutics's founding year is 2024
